术前口服镁负荷预防冠状动脉手术后术后心房颤动:一项前瞻性随机对照试验
该单中心、双盲、安慰剂对照、平行组随机试验于2018年11月至2019年5月纳入患者,评估冠状动脉旁路移植术前72小时口服镁负荷对术后心房颤动的影响。镁组与安慰剂组分别有10%与22%发生术后心房颤动(RR=0.45,95%CI 0.23-0.91),两组住院与重症监护病房住院时间相当,未记录到与补镁相关的不良反应。
要点
- 术前口服镁负荷3天可降低冠状动脉旁路移植术后心房颤动发生率(RR=0.45,95%CI 0.23-0.91)。
- 镁组术后心房颤动10% vs 安慰剂组22%。
- 两组住院与重症监护病房住院时间相当,未记录到与补镁相关的不良反应。
核心结论
- 在冠状动脉旁路移植术前接受3天口服镁负荷的患者中,与安慰剂相比,术后心房颤动的发生率降低。
研究设计与样本
- 单中心、双盲、安慰剂对照、平行组随机对照试验,1:1均衡随机化,2018年11月至2019年5月招募参与者。
- 随机分为镁组与安慰剂组:术前72小时每日口服镁3.2 g(每次4片、每片0.4 g,每日两次),手术当日口服镁1.6 g(4片);对照组服用安慰剂片。
- 210例随机参与者中200例(每组100例)完成研究。
主要发现
- 主要结局为术后心房颤动发生率:镁组10例(10%)vs 安慰剂组22例(22%)(RR=0.45,95%CI 0.23-0.91)。
- 次要结局包括拔管时间、输血率、重症监护病房与住院时间;两组住院与重症监护病房住院时间相当。
- 未记录到与补镁相关的不良反应。
关键数值与推荐
- 镁组术后心房颤动10例(10%)vs 安慰剂组22例(22%)(RR=0.45,95%CI 0.23-0.91)。
- 术前72小时每日口服镁3.2 g(4片×0.4 g,每日两次),手术当日口服镁1.6 g(4片)。
临床怎么用
- 作者认为,对因冠状动脉旁路移植手术入院的患者,术前口服镁负荷3天可降低术后心房颤动发生率。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Postoperative atrial fibrillation (POAF) is common following coronary artery bypass grafting (CABG) surgery. Hypomagnesemia is frequent after CABG surgery. No previous trials have assessed the effect of preoperative magnesium (Mg) loading on POAF incidence. METHODS: This was a single-centre, double-blind, placebo-controlled, parallel-group trial, with balanced randomization [1:1]. The participants were recruited from November 2018 until May 2019. Patients received either 3.2 g of Mg daily (4 tablets of 0.4 g each twice daily) for 72 h preoperatively and 1.6 g of Mg (4 tablets) on the day of surgery or placebo tablets. RESULTS: The primary outcome was the incidence of POAF. Secondary outcomes included time to extubation, transfusion rate, critical care unit and hospital length of stay. Of the 210 randomized participants, 200 (100 in each group) completed the study. A total of 10 (10%) and 22 (22%) subjects developed POAF in the Mg and placebo groups, respectively (RR = 0.45, 95% confidence interval: 0.23-0.91). Hospital and critical care unit length of stay were comparable between the 2 groups. No side effects related to Mg administration were documented. CONCLUSIONS: In this randomized controlled trial, preoperative loading with oral administration of Mg for 3 days in patients admitted for CABG surgery decreases the incidence of POAF compared to placebo. CLINICAL TRIAL REGISTRATION NUMBER: NCT03703349.
引用
- Tohme J, Sleilaty G, Jabbour K, et al. Preoperative oral magnesium loading to prevent postoperative atrial fibrillation following coronary surgery: a prospective randomized controlled trial. Eur J Cardiothorac Surg. 2022. PMID: 35451469. doi:10.1093/ejcts/ezac269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。